The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

LGND FINANCIAL STATEMENTS

Ligand Pharmaceuticals Incorporated — balance sheet, income statement and cash flow trends

LGNDLigand Pharmaceuticals Incorporated

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202020212022202420252026

Profit Funnel

Q2 2026 · TTM
Revenue290.5 M $Gross Profit289.6 M $ · 100%Operating Income100.9 M $ · 35%Pre-tax Income238 M $ · 82%Net Income to Owners197.2 M $ · 68%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue290.5 M $+54.9%
Gross Profit289.6 M $+76.1%
Operating Income100.9 M $—
EBITDA273.7 M $—
Net Income to Owners197.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202020212022202420252026

Capital Structure

Q2 2026
Total Assets2.2 B
  • Equity967.5 M $44%
  • Current Liabilities46.7 M $2%
  • Long-term Liabilities1.2 B $54%

Key Figures

YoY change
Total Assets2.2 B $+130.4%
Total Liabilities1.2 B $+914.7%
Total Equity967.5 M $+16.8%
Cash & ST Investments1.4 B $+431.8%
Total Debt1.1 B $+19,520.2%
Net Debt-231.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
050 M100 M202020212022202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M400 M131.6 M $Operating-144.8 M $Investing418 M $Financing404.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow131.6 M $+138.1%
Capital Expenditures278 K $-98.2%
Free Cash Flow131.4 M $+229.2%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on LGND

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.